Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-335 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-336 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D303-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-336 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
filingDate |
1996-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
1999-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-H11506421-A |
titleOfInvention |
Use of fumagillol and its derivatives for the preparation of a drug against intestinal infection |
abstract |
(57) Abstract: The present invention relates to fumagillol, and fumagillol and saturated or unsaturated (C 1 -C 12) for the preparation of a medicament for combating intestinal infections caused by microsporidia and / or cryptosporidia. ) alkyl carboxylic acid or (C 1 -C 12) ester formed by alkyl dicarboxylic acid, and the use of their pharmaceutically acceptable salts. |
priorityDate |
1995-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |